nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—BLK—hematopoietic system—malaria	0.0189	0.0649	CbGeAlD
Afatinib—ERBB2—saliva-secreting gland—malaria	0.0136	0.0466	CbGeAlD
Afatinib—ERBB4—saliva-secreting gland—malaria	0.0136	0.0466	CbGeAlD
Afatinib—ERBB2—hematopoietic system—malaria	0.013	0.0445	CbGeAlD
Afatinib—BLK—blood—malaria	0.0125	0.043	CbGeAlD
Afatinib—DYRK1A—hematopoietic system—malaria	0.0125	0.0428	CbGeAlD
Afatinib—ERBB2—kidney—malaria	0.0106	0.0365	CbGeAlD
Afatinib—Vandetanib—KDR—malaria	0.0105	1	CrCbGaD
Afatinib—DYRK1A—kidney—malaria	0.0102	0.0351	CbGeAlD
Afatinib—IRAK1—hematopoietic system—malaria	0.00971	0.0333	CbGeAlD
Afatinib—ERBB2—digestive system—malaria	0.00902	0.0309	CbGeAlD
Afatinib—ERBB2—blood—malaria	0.0086	0.0295	CbGeAlD
Afatinib—HIPK4—brain—malaria	0.00778	0.0267	CbGeAlD
Afatinib—PHKG2—liver—malaria	0.00748	0.0256	CbGeAlD
Afatinib—ERBB2—liver—malaria	0.00672	0.0231	CbGeAlD
Afatinib—DYRK1A—liver—malaria	0.00647	0.0222	CbGeAlD
Afatinib—IRAK1—blood—malaria	0.00643	0.022	CbGeAlD
Afatinib—Sepsis—Sulfadiazine—malaria	0.00631	0.0189	CcSEcCtD
Afatinib—LCK—blood—malaria	0.00627	0.0215	CbGeAlD
Afatinib—IRAK1—bone marrow—malaria	0.00622	0.0213	CbGeAlD
Afatinib—EPHA6—brain—malaria	0.00615	0.0211	CbGeAlD
Afatinib—LCK—bone marrow—malaria	0.00607	0.0208	CbGeAlD
Afatinib—Stomatitis—Proguanil—malaria	0.00597	0.0179	CcSEcCtD
Afatinib—PHKG2—brain—malaria	0.00593	0.0203	CbGeAlD
Afatinib—Hepatobiliary disease—Proguanil—malaria	0.00579	0.0173	CcSEcCtD
Afatinib—EGFR—liver—malaria	0.0057	0.0195	CbGeAlD
Afatinib—ABL1—saliva-secreting gland—malaria	0.0057	0.0195	CbGeAlD
Afatinib—ABL1—hematopoietic system—malaria	0.00544	0.0186	CbGeAlD
Afatinib—ERBB4—brain—malaria	0.00533	0.0183	CbGeAlD
Afatinib—ERBB2—brain—malaria	0.00533	0.0183	CbGeAlD
Afatinib—DYRK1A—brain—malaria	0.00513	0.0176	CbGeAlD
Afatinib—IRAK1—liver—malaria	0.00503	0.0172	CbGeAlD
Afatinib—Mediastinal disorder—Proguanil—malaria	0.00495	0.0148	CcSEcCtD
Afatinib—LCK—liver—malaria	0.0049	0.0168	CbGeAlD
Afatinib—Mental disorder—Proguanil—malaria	0.00482	0.0144	CcSEcCtD
Afatinib—Malnutrition—Proguanil—malaria	0.00479	0.0143	CcSEcCtD
Afatinib—EGFR—brain—malaria	0.00452	0.0155	CbGeAlD
Afatinib—ABL1—kidney—malaria	0.00446	0.0153	CbGeAlD
Afatinib—Decreased appetite—Pyrimethamine—malaria	0.00436	0.013	CcSEcCtD
Afatinib—Cough—Proguanil—malaria	0.00418	0.0125	CcSEcCtD
Afatinib—Renal impairment—Quinidine—malaria	0.00405	0.0121	CcSEcCtD
Afatinib—Renal impairment—Quinine—malaria	0.00405	0.0121	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00405	0.0121	CcSEcCtD
Afatinib—IRAK1—brain—malaria	0.00399	0.0137	CbGeAlD
Afatinib—Stomatitis—Sulfadiazine—malaria	0.00396	0.0119	CcSEcCtD
Afatinib—Nervous system disorder—Proguanil—malaria	0.00383	0.0115	CcSEcCtD
Afatinib—Skin disorder—Proguanil—malaria	0.00379	0.0114	CcSEcCtD
Afatinib—ABL1—digestive system—malaria	0.00378	0.013	CbGeAlD
Afatinib—Renal impairment—Quinidine barbiturate—malaria	0.00365	0.0109	CcSEcCtD
Afatinib—Nasopharyngitis—Dapsone—malaria	0.00363	0.0109	CcSEcCtD
Afatinib—ABL1—blood—malaria	0.0036	0.0124	CbGeAlD
Afatinib—Dry skin—Clindamycin—malaria	0.0036	0.0108	CcSEcCtD
Afatinib—ABCG2—saliva-secreting gland—malaria	0.00359	0.0123	CbGeAlD
Afatinib—ABL1—bone marrow—malaria	0.00349	0.012	CbGeAlD
Afatinib—Decreased appetite—Proguanil—malaria	0.00339	0.0102	CcSEcCtD
Afatinib—Gastrointestinal disorder—Proguanil—malaria	0.00337	0.0101	CcSEcCtD
Afatinib—Vomiting—Pyrimethamine—malaria	0.00319	0.00954	CcSEcCtD
Afatinib—Upper respiratory tract infection—Clindamycin—malaria	0.00315	0.00944	CcSEcCtD
Afatinib—Body temperature increased—Proguanil—malaria	0.00309	0.00924	CcSEcCtD
Afatinib—ABCB1—blood plasma—malaria	0.00306	0.0105	CbGeAlD
Afatinib—Urinary tract infection—Clindamycin—malaria	0.00294	0.0088	CcSEcCtD
Afatinib—Renal failure—Quinidine—malaria	0.00292	0.00873	CcSEcCtD
Afatinib—Renal failure—Quinine—malaria	0.00292	0.00873	CcSEcCtD
Afatinib—Epistaxis—Clindamycin—malaria	0.00285	0.00854	CcSEcCtD
Afatinib—ABL1—liver—malaria	0.00282	0.00966	CbGeAlD
Afatinib—Infestation—Pentoxifylline—malaria	0.00267	0.008	CcSEcCtD
Afatinib—Infestation NOS—Pentoxifylline—malaria	0.00267	0.008	CcSEcCtD
Afatinib—Diarrhoea—Proguanil—malaria	0.00267	0.008	CcSEcCtD
Afatinib—Renal failure—Quinidine barbiturate—malaria	0.00263	0.00788	CcSEcCtD
Afatinib—Urinary tract disorder—Quinidine—malaria	0.00263	0.00788	CcSEcCtD
Afatinib—Urinary tract disorder—Quinine—malaria	0.00263	0.00788	CcSEcCtD
Afatinib—Urethral disorder—Quinine—malaria	0.00261	0.00782	CcSEcCtD
Afatinib—Urethral disorder—Quinidine—malaria	0.00261	0.00782	CcSEcCtD
Afatinib—Conjunctivitis—Pentoxifylline—malaria	0.0026	0.00778	CcSEcCtD
Afatinib—Hepatobiliary disease—Pentoxifylline—malaria	0.00253	0.00757	CcSEcCtD
Afatinib—Epistaxis—Pentoxifylline—malaria	0.00252	0.00755	CcSEcCtD
Afatinib—Eye disorder—Quinine—malaria	0.00249	0.00745	CcSEcCtD
Afatinib—Eye disorder—Quinidine—malaria	0.00249	0.00745	CcSEcCtD
Afatinib—Vomiting—Proguanil—malaria	0.00248	0.00743	CcSEcCtD
Afatinib—Rash—Proguanil—malaria	0.00246	0.00737	CcSEcCtD
Afatinib—Dermatitis—Proguanil—malaria	0.00246	0.00736	CcSEcCtD
Afatinib—Headache—Proguanil—malaria	0.00245	0.00732	CcSEcCtD
Afatinib—Mediastinal disorder—Quinine—malaria	0.0024	0.00719	CcSEcCtD
Afatinib—Mediastinal disorder—Quinidine—malaria	0.0024	0.00719	CcSEcCtD
Afatinib—Urinary tract disorder—Quinidine barbiturate—malaria	0.00238	0.00711	CcSEcCtD
Afatinib—Urethral disorder—Quinidine barbiturate—malaria	0.00236	0.00706	CcSEcCtD
Afatinib—Insomnia—Sulfadiazine—malaria	0.00234	0.00702	CcSEcCtD
Afatinib—Mental disorder—Quinidine—malaria	0.00234	0.00699	CcSEcCtD
Afatinib—Mental disorder—Quinine—malaria	0.00234	0.00699	CcSEcCtD
Afatinib—Malnutrition—Quinine—malaria	0.00232	0.00694	CcSEcCtD
Afatinib—Malnutrition—Quinidine—malaria	0.00232	0.00694	CcSEcCtD
Afatinib—Nausea—Proguanil—malaria	0.00232	0.00694	CcSEcCtD
Afatinib—Dysgeusia—Clindamycin—malaria	0.00232	0.00693	CcSEcCtD
Afatinib—Back pain—Clindamycin—malaria	0.00229	0.00685	CcSEcCtD
Afatinib—Muscle spasms—Clindamycin—malaria	0.00227	0.00681	CcSEcCtD
Afatinib—ABCG2—blood—malaria	0.00227	0.00779	CbGeAlD
Afatinib—Decreased appetite—Sulfadiazine—malaria	0.00225	0.00674	CcSEcCtD
Afatinib—Eye disorder—Quinidine barbiturate—malaria	0.00225	0.00673	CcSEcCtD
Afatinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.00224	0.0067	CcSEcCtD
Afatinib—ABL1—brain—malaria	0.00224	0.00766	CbGeAlD
Afatinib—ABCG2—bone marrow—malaria	0.0022	0.00754	CbGeAlD
Afatinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.00217	0.00649	CcSEcCtD
Afatinib—Cough—Dapsone—malaria	0.00213	0.00639	CcSEcCtD
Afatinib—Mental disorder—Quinidine barbiturate—malaria	0.00211	0.00631	CcSEcCtD
Afatinib—Malnutrition—Quinidine barbiturate—malaria	0.00209	0.00627	CcSEcCtD
Afatinib—Body temperature increased—Sulfadiazine—malaria	0.00205	0.00613	CcSEcCtD
Afatinib—Dysgeusia—Pentoxifylline—malaria	0.00205	0.00613	CcSEcCtD
Afatinib—Back pain—Pentoxifylline—malaria	0.00202	0.00605	CcSEcCtD
Afatinib—Muscle spasms—Pentoxifylline—malaria	0.00201	0.00601	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00196	0.00587	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00196	0.00587	CcSEcCtD
Afatinib—Nervous system disorder—Quinine—malaria	0.00186	0.00556	CcSEcCtD
Afatinib—Nervous system disorder—Quinidine—malaria	0.00186	0.00556	CcSEcCtD
Afatinib—Skin disorder—Quinine—malaria	0.00184	0.0055	CcSEcCtD
Afatinib—Skin disorder—Quinidine—malaria	0.00184	0.0055	CcSEcCtD
Afatinib—Pruritus—Sulfadiazine—malaria	0.00183	0.00549	CcSEcCtD
Afatinib—Insomnia—Dapsone—malaria	0.00181	0.0054	CcSEcCtD
Afatinib—ABCG2—liver—malaria	0.00178	0.00609	CbGeAlD
Afatinib—Diarrhoea—Sulfadiazine—malaria	0.00177	0.00531	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00177	0.0053	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00177	0.00529	CcSEcCtD
Afatinib—Dyspnoea—Clindamycin—malaria	0.00172	0.00515	CcSEcCtD
Afatinib—Dyspepsia—Clindamycin—malaria	0.0017	0.00508	CcSEcCtD
Afatinib—Infection—Pentoxifylline—malaria	0.00169	0.00507	CcSEcCtD
Afatinib—ABCB1—hematopoietic system—malaria	0.00169	0.0058	CbGeAlD
Afatinib—Dyspnoea—Quinine—malaria	0.00169	0.00505	CcSEcCtD
Afatinib—Dyspnoea—Quinidine—malaria	0.00169	0.00505	CcSEcCtD
Afatinib—Nervous system disorder—Quinidine barbiturate—malaria	0.00168	0.00502	CcSEcCtD
Afatinib—Gastrointestinal disorder—Clindamycin—malaria	0.00167	0.00499	CcSEcCtD
Afatinib—Fatigue—Clindamycin—malaria	0.00166	0.00498	CcSEcCtD
Afatinib—Skin disorder—Quinidine barbiturate—malaria	0.00166	0.00497	CcSEcCtD
Afatinib—Skin disorder—Pentoxifylline—malaria	0.00166	0.00496	CcSEcCtD
Afatinib—Constipation—Clindamycin—malaria	0.00165	0.00494	CcSEcCtD
Afatinib—Vomiting—Sulfadiazine—malaria	0.00165	0.00493	CcSEcCtD
Afatinib—Decreased appetite—Quinine—malaria	0.00165	0.00493	CcSEcCtD
Afatinib—Decreased appetite—Quinidine—malaria	0.00165	0.00493	CcSEcCtD
Afatinib—Gastrointestinal disorder—Quinine—malaria	0.00163	0.00489	CcSEcCtD
Afatinib—Gastrointestinal disorder—Quinidine—malaria	0.00163	0.00489	CcSEcCtD
Afatinib—Rash—Sulfadiazine—malaria	0.00163	0.00489	CcSEcCtD
Afatinib—Dermatitis—Sulfadiazine—malaria	0.00163	0.00489	CcSEcCtD
Afatinib—Headache—Sulfadiazine—malaria	0.00162	0.00486	CcSEcCtD
Afatinib—Body temperature increased—Dapsone—malaria	0.00158	0.00472	CcSEcCtD
Afatinib—Insomnia—Pentoxifylline—malaria	0.00154	0.00462	CcSEcCtD
Afatinib—Nausea—Sulfadiazine—malaria	0.00154	0.00461	CcSEcCtD
Afatinib—Body temperature increased—Clindamycin—malaria	0.00153	0.00457	CcSEcCtD
Afatinib—Dyspnoea—Quinidine barbiturate—malaria	0.00152	0.00456	CcSEcCtD
Afatinib—Dyspnoea—Pentoxifylline—malaria	0.00152	0.00455	CcSEcCtD
Afatinib—Dyspepsia—Pentoxifylline—malaria	0.0015	0.00449	CcSEcCtD
Afatinib—Body temperature increased—Quinidine—malaria	0.0015	0.00448	CcSEcCtD
Afatinib—Body temperature increased—Quinine—malaria	0.0015	0.00448	CcSEcCtD
Afatinib—Decreased appetite—Quinidine barbiturate—malaria	0.00149	0.00445	CcSEcCtD
Afatinib—Decreased appetite—Pentoxifylline—malaria	0.00148	0.00444	CcSEcCtD
Afatinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00148	0.00442	CcSEcCtD
Afatinib—Constipation—Quinidine barbiturate—malaria	0.00146	0.00437	CcSEcCtD
Afatinib—Constipation—Pentoxifylline—malaria	0.00146	0.00437	CcSEcCtD
Afatinib—ABCG2—brain—malaria	0.00141	0.00483	CbGeAlD
Afatinib—ABCB1—kidney—malaria	0.00139	0.00475	CbGeAlD
Afatinib—Asthenia—Clindamycin—malaria	0.00139	0.00414	CcSEcCtD
Afatinib—Pruritus—Clindamycin—malaria	0.00137	0.00409	CcSEcCtD
Afatinib—Asthenia—Quinidine—malaria	0.00136	0.00407	CcSEcCtD
Afatinib—Asthenia—Quinine—malaria	0.00136	0.00407	CcSEcCtD
Afatinib—Body temperature increased—Quinidine barbiturate—malaria	0.00135	0.00404	CcSEcCtD
Afatinib—Body temperature increased—Pentoxifylline—malaria	0.00135	0.00404	CcSEcCtD
Afatinib—Pruritus—Quinine—malaria	0.00134	0.00401	CcSEcCtD
Afatinib—Pruritus—Quinidine—malaria	0.00134	0.00401	CcSEcCtD
Afatinib—Diarrhoea—Clindamycin—malaria	0.00132	0.00395	CcSEcCtD
Afatinib—Diarrhoea—Quinine—malaria	0.0013	0.00388	CcSEcCtD
Afatinib—Diarrhoea—Quinidine—malaria	0.0013	0.00388	CcSEcCtD
Afatinib—Dizziness—Clindamycin—malaria	0.00128	0.00382	CcSEcCtD
Afatinib—Vomiting—Dapsone—malaria	0.00127	0.0038	CcSEcCtD
Afatinib—Dizziness—Quinidine—malaria	0.00125	0.00375	CcSEcCtD
Afatinib—Dizziness—Quinine—malaria	0.00125	0.00375	CcSEcCtD
Afatinib—Headache—Dapsone—malaria	0.00125	0.00374	CcSEcCtD
Afatinib—Vomiting—Clindamycin—malaria	0.00123	0.00367	CcSEcCtD
Afatinib—Asthenia—Quinidine barbiturate—malaria	0.00123	0.00367	CcSEcCtD
Afatinib—Asthenia—Pentoxifylline—malaria	0.00122	0.00366	CcSEcCtD
Afatinib—Rash—Clindamycin—malaria	0.00122	0.00364	CcSEcCtD
Afatinib—Dermatitis—Clindamycin—malaria	0.00122	0.00364	CcSEcCtD
Afatinib—Headache—Clindamycin—malaria	0.00121	0.00362	CcSEcCtD
Afatinib—Pruritus—Quinidine barbiturate—malaria	0.00121	0.00362	CcSEcCtD
Afatinib—Pruritus—Pentoxifylline—malaria	0.00121	0.00361	CcSEcCtD
Afatinib—Vomiting—Quinine—malaria	0.0012	0.0036	CcSEcCtD
Afatinib—Vomiting—Quinidine—malaria	0.0012	0.0036	CcSEcCtD
Afatinib—Rash—Quinidine—malaria	0.00119	0.00357	CcSEcCtD
Afatinib—Rash—Quinine—malaria	0.00119	0.00357	CcSEcCtD
Afatinib—Dermatitis—Quinidine—malaria	0.00119	0.00357	CcSEcCtD
Afatinib—Dermatitis—Quinine—malaria	0.00119	0.00357	CcSEcCtD
Afatinib—Headache—Quinine—malaria	0.00119	0.00355	CcSEcCtD
Afatinib—Headache—Quinidine—malaria	0.00119	0.00355	CcSEcCtD
Afatinib—Nausea—Dapsone—malaria	0.00119	0.00355	CcSEcCtD
Afatinib—ABCB1—digestive system—malaria	0.00118	0.00403	CbGeAlD
Afatinib—Diarrhoea—Quinidine barbiturate—malaria	0.00117	0.0035	CcSEcCtD
Afatinib—Diarrhoea—Pentoxifylline—malaria	0.00117	0.00349	CcSEcCtD
Afatinib—Nausea—Clindamycin—malaria	0.00115	0.00343	CcSEcCtD
Afatinib—Dizziness—Quinidine barbiturate—malaria	0.00113	0.00338	CcSEcCtD
Afatinib—Dizziness—Pentoxifylline—malaria	0.00113	0.00338	CcSEcCtD
Afatinib—Nausea—Quinine—malaria	0.00112	0.00337	CcSEcCtD
Afatinib—Nausea—Quinidine—malaria	0.00112	0.00337	CcSEcCtD
Afatinib—ABCB1—blood—malaria	0.00112	0.00384	CbGeAlD
Afatinib—Vomiting—Quinidine barbiturate—malaria	0.00109	0.00325	CcSEcCtD
Afatinib—Vomiting—Pentoxifylline—malaria	0.00108	0.00325	CcSEcCtD
Afatinib—ABCB1—bone marrow—malaria	0.00108	0.00372	CbGeAlD
Afatinib—Rash—Quinidine barbiturate—malaria	0.00108	0.00322	CcSEcCtD
Afatinib—Dermatitis—Quinidine barbiturate—malaria	0.00108	0.00322	CcSEcCtD
Afatinib—Rash—Pentoxifylline—malaria	0.00108	0.00322	CcSEcCtD
Afatinib—Dermatitis—Pentoxifylline—malaria	0.00107	0.00322	CcSEcCtD
Afatinib—Headache—Quinidine barbiturate—malaria	0.00107	0.0032	CcSEcCtD
Afatinib—Headache—Pentoxifylline—malaria	0.00107	0.0032	CcSEcCtD
Afatinib—Nausea—Quinidine barbiturate—malaria	0.00102	0.00304	CcSEcCtD
Afatinib—Nausea—Pentoxifylline—malaria	0.00101	0.00303	CcSEcCtD
Afatinib—ABCB1—liver—malaria	0.000876	0.003	CbGeAlD
Afatinib—ABCB1—brain—malaria	0.000695	0.00238	CbGeAlD
Afatinib—ERBB4—Immune System—CD8A—malaria	0.000195	0.000535	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—CD4—malaria	0.000192	0.000528	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HLA-B—malaria	0.00019	0.000523	CbGpPWpGaD
Afatinib—BLK—Immune System—IL18—malaria	0.00019	0.000523	CbGpPWpGaD
Afatinib—BLK—Immune System—CD40LG—malaria	0.000189	0.000521	CbGpPWpGaD
Afatinib—EGFR—Disease—G6PD—malaria	0.000189	0.000521	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TLR9—malaria	0.000189	0.00052	CbGpPWpGaD
Afatinib—LCK—Immune System—TLR9—malaria	0.000189	0.000518	CbGpPWpGaD
Afatinib—LCK—Signaling by Interleukins—IL6—malaria	0.000188	0.000516	CbGpPWpGaD
Afatinib—BLK—Immune System—CD8A—malaria	0.000187	0.000515	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HLA-B—malaria	0.000187	0.000515	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—CD4—malaria	0.000187	0.000515	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD36—malaria	0.000186	0.000513	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—HBB—malaria	0.000186	0.000512	CbGpPWpGaD
Afatinib—ERBB2—Signaling by NGF—IL6—malaria	0.000185	0.000508	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—HLA-B—malaria	0.000185	0.000508	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—CD4—malaria	0.000184	0.000507	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD36—malaria	0.000184	0.000505	CbGpPWpGaD
Afatinib—ABL1—Immune System—FCGR2A—malaria	0.000183	0.000503	CbGpPWpGaD
Afatinib—LCK—Disease—G6PD—malaria	0.000183	0.000502	CbGpPWpGaD
Afatinib—ERBB4—Signaling by NGF—IL6—malaria	0.000182	0.000501	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000182	0.0005	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—IL6—malaria	0.000181	0.000499	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CD36—malaria	0.000181	0.000498	CbGpPWpGaD
Afatinib—BLK—Immune System—HLA-B—malaria	0.00018	0.000495	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—IL2—malaria	0.00018	0.000495	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000179	0.000492	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—CD4—malaria	0.000177	0.000488	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—KDR—malaria	0.000177	0.000487	CbGpPWpGaD
Afatinib—BLK—Immune System—CD36—malaria	0.000177	0.000486	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—CD36—malaria	0.000175	0.000482	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TNF—malaria	0.000169	0.000466	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CRP—malaria	0.000168	0.000462	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IFNG—malaria	0.000168	0.000461	CbGpPWpGaD
Afatinib—ERBB2—Axon guidance—IL6—malaria	0.000167	0.00046	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PKLR—malaria	0.000166	0.000457	CbGpPWpGaD
Afatinib—LCK—Hemostasis—CD36—malaria	0.000166	0.000455	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CRP—malaria	0.000166	0.000455	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—NOS2—malaria	0.000165	0.000455	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CRP—malaria	0.000163	0.000449	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—IL6—malaria	0.000161	0.000443	CbGpPWpGaD
Afatinib—ERBB2—Immune System—TLR4—malaria	0.000161	0.000443	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD40LG—malaria	0.000159	0.000438	CbGpPWpGaD
Afatinib—BLK—Immune System—CRP—malaria	0.000159	0.000438	CbGpPWpGaD
Afatinib—ERBB4—Immune System—TLR4—malaria	0.000159	0.000436	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—HLA-B—malaria	0.000158	0.000434	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD8A—malaria	0.000158	0.000433	CbGpPWpGaD
Afatinib—EGFR—Signaling by SCF-KIT—IL6—malaria	0.000157	0.000433	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ACKR1—malaria	0.000157	0.000432	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—TLR4—malaria	0.000157	0.00043	CbGpPWpGaD
Afatinib—EGFR—Immune System—FCGR2A—malaria	0.000156	0.00043	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—TNF—malaria	0.000156	0.00043	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD36—malaria	0.000155	0.000425	CbGpPWpGaD
Afatinib—ERBB2—Immune System—ICAM1—malaria	0.000154	0.000425	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD40LG—malaria	0.000154	0.000422	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000153	0.00042	CbGpPWpGaD
Afatinib—BLK—Immune System—TLR4—malaria	0.000153	0.00042	CbGpPWpGaD
Afatinib—ERBB4—Immune System—ICAM1—malaria	0.000152	0.000418	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—HLA-B—malaria	0.000152	0.000418	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD8A—malaria	0.000152	0.000417	CbGpPWpGaD
Afatinib—LCK—Signaling by SCF-KIT—IL6—malaria	0.000152	0.000417	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HLA-B—malaria	0.000152	0.000417	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—KDR—malaria	0.000151	0.000416	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ACKR1—malaria	0.000151	0.000416	CbGpPWpGaD
Afatinib—LCK—Immune System—FCGR2A—malaria	0.000151	0.000414	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling of activated FGFR—IL6—malaria	0.000151	0.000414	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL1B—malaria	0.00015	0.000411	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD36—malaria	0.000149	0.00041	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL2—malaria	0.000149	0.00041	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD36—malaria	0.000149	0.000409	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB4—IL6—malaria	0.000148	0.000407	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—G6PD—malaria	0.000148	0.000407	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—TNF—malaria	0.000148	0.000407	CbGpPWpGaD
Afatinib—BLK—Immune System—ICAM1—malaria	0.000146	0.000402	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HLA-B—malaria	0.000146	0.000402	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL18—malaria	0.000145	0.000399	CbGpPWpGaD
Afatinib—LCK—Downstream signaling of activated FGFR—IL6—malaria	0.000145	0.000399	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD40LG—malaria	0.000145	0.000397	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD36—malaria	0.000143	0.000394	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD8A—malaria	0.000143	0.000393	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB4—IL6—malaria	0.000143	0.000393	CbGpPWpGaD
Afatinib—ERBB2—Disease—NOS2—malaria	0.000142	0.000389	CbGpPWpGaD
Afatinib—EGFR—Downstream signal transduction—IL6—malaria	0.000141	0.000389	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—CD4—malaria	0.000141	0.000387	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR—IL6—malaria	0.000141	0.000387	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB2—IL6—malaria	0.00014	0.000385	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CRP—malaria	0.00014	0.000384	CbGpPWpGaD
Afatinib—EGFR—DAP12 signaling—IL6—malaria	0.000139	0.000383	CbGpPWpGaD
Afatinib—ERBB4—Disease—NOS2—malaria	0.000139	0.000383	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DHODH—malaria	0.000139	0.000383	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-B—malaria	0.000137	0.000378	CbGpPWpGaD
Afatinib—LCK—Downstream signal transduction—IL6—malaria	0.000136	0.000375	CbGpPWpGaD
Afatinib—LCK—Hemostasis—NOS2—malaria	0.000136	0.000374	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—IL6—malaria	0.000136	0.000374	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR—IL6—malaria	0.000136	0.000373	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB2—IL6—malaria	0.000135	0.000371	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD36—malaria	0.000135	0.000371	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CRP—malaria	0.000134	0.00037	CbGpPWpGaD
Afatinib—LCK—DAP12 signaling—IL6—malaria	0.000134	0.000369	CbGpPWpGaD
Afatinib—EGFR—Disease—DHFR—malaria	0.000134	0.000368	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—TLR4—malaria	0.000134	0.000368	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—IL6—malaria	0.000134	0.000367	CbGpPWpGaD
Afatinib—EGFR—DAP12 interactions—IL6—malaria	0.000131	0.000361	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—malaria	0.000131	0.000361	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR in disease—IL6—malaria	0.000131	0.000361	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR—IL6—malaria	0.00013	0.000357	CbGpPWpGaD
Afatinib—LCK—Disease—DHFR—malaria	0.000129	0.000355	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—TLR4—malaria	0.000129	0.000354	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR in Cancer—IL6—malaria	0.000129	0.000354	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—IL6—malaria	0.000128	0.000353	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TLR9—malaria	0.000127	0.000348	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR in disease—IL6—malaria	0.000126	0.000348	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—IL6—malaria	0.000126	0.000348	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—IL6—malaria	0.000126	0.000348	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR—IL6—malaria	0.000125	0.000344	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR in Cancer—IL6—malaria	0.000124	0.000341	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—IL6—malaria	0.000124	0.00034	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—ICAM1—malaria	0.000123	0.000339	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TLR9—malaria	0.000122	0.000335	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CRP—malaria	0.000122	0.000334	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—IL6—malaria	0.000119	0.000328	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—ICAM1—malaria	0.000119	0.000326	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SLC4A1—malaria	0.000119	0.000326	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IFNG—malaria	0.000118	0.000323	CbGpPWpGaD
Afatinib—IRAK1—Immune System—TLR4—malaria	0.000117	0.00032	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—malaria	0.000116	0.000319	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IFNG—malaria	0.000116	0.000318	CbGpPWpGaD
Afatinib—PHKG2—Disease—IL6—malaria	0.000114	0.000314	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL18—malaria	0.000114	0.000312	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD4—malaria	0.000114	0.000312	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD40LG—malaria	0.000113	0.000311	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—HPGDS—malaria	0.000113	0.00031	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—IL2—malaria	0.000113	0.00031	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	0.000112	0.000309	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—malaria	0.000112	0.000308	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD8A—malaria	0.000112	0.000307	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD4—malaria	0.000112	0.000307	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ICAM1—malaria	0.000112	0.000307	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DECR1—malaria	0.000111	0.000306	CbGpPWpGaD
Afatinib—BLK—Immune System—IFNG—malaria	0.000111	0.000306	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CD4—malaria	0.00011	0.000303	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-B—malaria	0.000108	0.000296	CbGpPWpGaD
Afatinib—BLK—Immune System—CD4—malaria	0.000108	0.000296	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD36—malaria	0.000105	0.00029	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—IL6—malaria	0.000105	0.00029	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL1B—malaria	0.000105	0.000288	CbGpPWpGaD
Afatinib—ERBB2—Disease—CD4—malaria	0.000105	0.000288	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—DHFR—malaria	0.000105	0.000288	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL2—malaria	0.000104	0.000287	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—KDR—malaria	0.000104	0.000286	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—IL6—malaria	0.000104	0.000285	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—SCARB1—malaria	0.000104	0.000285	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL1B—malaria	0.000103	0.000284	CbGpPWpGaD
Afatinib—ERBB4—Disease—CD4—malaria	0.000103	0.000284	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL2—malaria	0.000103	0.000283	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—KDR—malaria	0.000103	0.000282	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—HBB—malaria	0.000101	0.000277	CbGpPWpGaD
Afatinib—BLK—Immune System—IL1B—malaria	9.94e-05	0.000273	CbGpPWpGaD
Afatinib—BLK—Immune System—IL2—malaria	9.9e-05	0.000272	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL18—malaria	9.7e-05	0.000267	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD40LG—malaria	9.66e-05	0.000266	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD8A—malaria	9.56e-05	0.000263	CbGpPWpGaD
Afatinib—ABL1—Immune System—CRP—malaria	9.51e-05	0.000261	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—IL6—malaria	9.46e-05	0.00026	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD4—malaria	9.42e-05	0.000259	CbGpPWpGaD
Afatinib—LCK—Immune System—IL18—malaria	9.35e-05	0.000257	CbGpPWpGaD
Afatinib—LCK—Immune System—CD40LG—malaria	9.31e-05	0.000256	CbGpPWpGaD
Afatinib—LCK—Hemostasis—IL2—malaria	9.28e-05	0.000255	CbGpPWpGaD
Afatinib—LCK—Immune System—CD8A—malaria	9.21e-05	0.000253	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-B—malaria	9.19e-05	0.000253	CbGpPWpGaD
Afatinib—ABL1—Immune System—TLR4—malaria	9.12e-05	0.000251	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD4—malaria	9.08e-05	0.00025	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD4—malaria	9.05e-05	0.000249	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD36—malaria	9.01e-05	0.000248	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PKLR—malaria	8.98e-05	0.000247	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—IL6—malaria	8.94e-05	0.000246	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-B—malaria	8.86e-05	0.000244	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL6—malaria	8.76e-05	0.000241	CbGpPWpGaD
Afatinib—ABL1—Immune System—ICAM1—malaria	8.74e-05	0.00024	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD4—malaria	8.72e-05	0.00024	CbGpPWpGaD
Afatinib—LCK—Immune System—CD36—malaria	8.69e-05	0.000239	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—IL6—malaria	8.61e-05	0.000237	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IFNG—malaria	8.5e-05	0.000234	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—malaria	8.37e-05	0.00023	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD4—malaria	8.21e-05	0.000226	CbGpPWpGaD
Afatinib—EGFR—Immune System—CRP—malaria	8.13e-05	0.000223	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—IL6—malaria	8.09e-05	0.000222	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—G6PD—malaria	8.01e-05	0.00022	CbGpPWpGaD
Afatinib—LCK—Immune System—CRP—malaria	7.83e-05	0.000215	CbGpPWpGaD
Afatinib—EGFR—Immune System—TLR4—malaria	7.79e-05	0.000214	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	7.72e-05	0.000212	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—IL6—malaria	7.62e-05	0.00021	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL1B—malaria	7.58e-05	0.000208	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL2—malaria	7.55e-05	0.000208	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—KDR—malaria	7.53e-05	0.000207	CbGpPWpGaD
Afatinib—LCK—Immune System—TLR4—malaria	7.51e-05	0.000206	CbGpPWpGaD
Afatinib—EGFR—Immune System—ICAM1—malaria	7.47e-05	0.000205	CbGpPWpGaD
Afatinib—LCK—Immune System—ICAM1—malaria	7.2e-05	0.000198	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—malaria	7.15e-05	0.000197	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS2—malaria	6.84e-05	0.000188	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL2—malaria	6.75e-05	0.000186	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—IL6—malaria	6.75e-05	0.000186	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL2—malaria	6.65e-05	0.000183	CbGpPWpGaD
Afatinib—ABL1—Immune System—IFNG—malaria	6.65e-05	0.000183	CbGpPWpGaD
Afatinib—LCK—Disease—NOS2—malaria	6.59e-05	0.000181	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CD36—malaria	6.51e-05	0.000179	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD4—malaria	6.42e-05	0.000177	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—malaria	6.14e-05	0.000169	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—HPGDS—malaria	6.11e-05	0.000168	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—malaria	6.05e-05	0.000166	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—malaria	5.96e-05	0.000164	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL1B—malaria	5.93e-05	0.000163	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2—malaria	5.91e-05	0.000162	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—malaria	5.82e-05	0.00016	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—malaria	5.77e-05	0.000159	CbGpPWpGaD
Afatinib—EGFR—Immune System—IFNG—malaria	5.68e-05	0.000156	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—malaria	5.67e-05	0.000156	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DHFR—malaria	5.66e-05	0.000156	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SCARB1—malaria	5.61e-05	0.000154	CbGpPWpGaD
Afatinib—ERBB4—Disease—IL6—malaria	5.58e-05	0.000154	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2—malaria	5.53e-05	0.000152	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD4—malaria	5.49e-05	0.000151	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNG—malaria	5.48e-05	0.000151	CbGpPWpGaD
Afatinib—LCK—Immune System—CD4—malaria	5.29e-05	0.000145	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—malaria	5.1e-05	0.00014	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL1B—malaria	5.07e-05	0.000139	CbGpPWpGaD
Afatinib—EGFR—Disease—CD4—malaria	5.07e-05	0.000139	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2—malaria	5.05e-05	0.000139	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KDR—malaria	5.04e-05	0.000138	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—malaria	4.91e-05	0.000135	CbGpPWpGaD
Afatinib—LCK—Immune System—IL1B—malaria	4.89e-05	0.000134	CbGpPWpGaD
Afatinib—LCK—Disease—CD4—malaria	4.88e-05	0.000134	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2—malaria	4.88e-05	0.000134	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2—malaria	4.87e-05	0.000134	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KDR—malaria	4.85e-05	0.000133	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—malaria	4.44e-05	0.000122	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—malaria	3.97e-05	0.000109	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—malaria	3.91e-05	0.000108	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CD36—malaria	3.52e-05	9.67e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—malaria	3.47e-05	9.55e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2—malaria	3.27e-05	8.98e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—malaria	3.25e-05	8.93e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2—malaria	3.15e-05	8.65e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—malaria	2.97e-05	8.16e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—malaria	2.87e-05	7.89e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—malaria	2.86e-05	7.86e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—malaria	2.74e-05	7.53e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—malaria	2.64e-05	7.26e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—malaria	1.92e-05	5.28e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—malaria	1.85e-05	5.08e-05	CbGpPWpGaD
